Skip to main content

Johnson & Johnson to Participate in the Leerink Global Biopharma Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Leerink Global Biopharma Conference on Tuesday, March 12th, at the Fontainebleau Miami Beach, FL. Joe Wolk, Executive Vice President, Chief Financial Officer will represent the Company in a session scheduled at 1:00 p.m. (Eastern Time).

This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48-hrs after the webcast.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  207.91
-3.80 (-1.79%)
AAPL  253.90
+1.28 (0.51%)
AMD  204.36
-15.91 (-7.22%)
BAC  48.26
-0.49 (-1.00%)
GOOG  280.45
-9.14 (-3.16%)
META  546.64
-48.25 (-8.11%)
MSFT  366.01
-5.03 (-1.36%)
NVDA  171.78
-6.90 (-3.86%)
ORCL  143.28
-2.74 (-1.88%)
TSLA  372.77
-13.18 (-3.41%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.